.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Scientists investigate Connaraceae phenolic compounds for their promising antibacterial and antioxidant effects. A recent study examined three lesser-known Brazilian species: Rourea fluminensis, Connarus nodosus, and Connarus ruber. Researchers identified bioactive markers and evaluated their therapeutic potential. These findings contribute to the growing body of knowledge on natural products.
Furthermore, the extracts showed strong antioxidant capacity against DPPH and ABTS radicals. Notably, the study revealed antibacterial activity against Staphylococcus aureus. Consequently, these plants represent a potential source for new anti-infective developments.
LC-HRMS characterisation pinpointed 13 specific compounds in the extracts. The results highlighted myricetin glycosides, guaijaverin glycosides, and chlorogenic acid. These molecules likely drive the observed redox and antibacterial activities. Moreover, the extracts demonstrated no toxicity to Artemia salina at 1000 µg/mL. This safety profile encourages further investigation into their medicinal use.
In summary, this research marks the first chemical characterisation of these endemic species. Such insights assist in developing treatments for oxidative stress and infections.
The study demonstrated that these plant extracts possess antibacterial activity against Staphylococcus aureus.
Researchers identified 13 compounds, including myricetin glycosides, guaijaverin glycosides, and chlorogenic acid, as key bioactive markers.
No, the extracts showed no toxicity to Artemia salina at a concentration of 1000 µg/mL.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Turcatel GA et al. Exploring the chemical profiles and biological activities of three lesser-known connaraceae species rich in phenolic compounds. Nat Prod Res. 2026 Apr 09. doi: 10.1080/14786419.2026.2655405. PMID: 41955641.
2. Osman CP, Zahari Z, Adenan MI, Zohdi RM. A review on traditional uses, phytochemistry, and pharmacology of the genus Rourea. J Appl Pharm Sci. 2019;9(09):125–131.
3. Nogueira-Silva L, et al. Myricetin protects Galleria mellonella against Staphylococcus aureus infection and inhibits multiple virulence factors. Scientific Reports. 2020;10:6023.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Study highlights the antioxidant and anti-Staphylococcal properties of three Brazilian Connaraceae species rich in myricetin and chlorogenic acid....
6 months ago
Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today
A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday
